Scalzo Richard William
SEC CIK 1789545 · EDGAR
BoughtSold
Most active insiders at CBIO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Harwin Peter Evan | Dir, 10% | $18.24M | — |
| 2 | Fairmount Funds Management LLC | Dir, 10% | $12.38M | — |
| 3 | Brumm Joshua T | CEO, Dir | — | $920.8K |
| 4 | McNeill Jonathan | Pres, COO | — | $446.9K |
| 5 | Pinkas Jan | CSO | — | $34.9K |
| 6 | Im Ellie Eunkyung | Chief Medical Off | — | $33.1K |
| 7 | Bispham Barbara Harlin | See Remarks | — | $33.0K |
| 8 | Scalzo Richard William | CFO | — | $30.2K |
| 9 | Lynch Ryan | See Remarks | — | $12.7K |
| 10 | Doughty Christopher Grant | Chief Business Off | — | — |
Transactions 42
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-18 16:02 | 2026-09-16 | CBIO | CRESCENT BIOPHARMA, INC. | Scalzo Richard William | CFO | S - Sale | $17.90 | -568 | 19.7K | -3% | -$10.2K |
| T | 2026-06-23 16:03 | 2026-06-22 | CBIO | CRESCENT BIOPHARMA, INC. | Scalzo Richard William | CFO | S - Sale | $17.99 | -1,112 | 20.3K | -5% | -$20.0K |
| DM | 2025-12-17 | 2025-12-15 | CBIO | CRESCENT BIOPHARMA, INC. | Scalzo Richard William | CFO | A - Grant | — | +19.4K | 19.4K | New | — |
| T | 2025-03-13 | 2025-03-11 | DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | SVP, Head of Fin, Admin | S - Sale | $11.38 | -1,343 | 122.3K | -1% | -$15.3K |
| T | 2025-03-07 | 2025-03-05 | DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | SVP, Head of Fin, Admin | S - Sale | $11.83 | -917 | 123.7K | -0.7% | -$10.8K |
| T | 2025-02-18 | 2025-02-18 | DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | SVP, Head of Fin, Admin | S - Sale | $13.95 | -2,488 | 124.6K | -2% | -$34.7K |
| T | 2024-12-11 | 2024-12-11 | DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | SVP, Head of Fin, Admin | S - Sale | $28.12 | -1,455 | 127.1K | -1% | -$40.9K |
| D | 2024-12-06 | 2024-12-04 | DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | SVP, Head of Fin, Admin | A - Grant | $0.00 | +32.7K | 128.5K | +34% | $0 |
| T | 2024-11-18 | 2024-11-18 | DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | SVP, Head of Fin, Admin | S - Sale | $28.20 | -2,735 | 95.8K | -3% | -$77.1K |
| T | 2024-09-19 | 2024-09-18 | DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | SVP, Head of Fin, Admin | S - Sale | $34.55 | -1,390 | 98.6K | -1% | -$48.0K |
| T | 2024-09-11 | 2024-09-11 | DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | SVP, Head of Fin, Admin | S - Sale | $31.89 | -1,468 | 100.0K | -1% | -$46.8K |
| DM | 2024-09-10 | 2024-09-06 | DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | SVP, Head of Fin, Admin | M - OptEx | $12.56 | +116.5K | 117.5K | +11,136% | +$1.46M |
| DM | 2024-09-10 | 2024-09-06 | DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | SVP, Head of Fin, Admin | S - Sale+OE | $32.15 | -126.1K | 103.1K | -55% | -$4.05M |
| MT | 2024-08-20 | 2024-08-19 | DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | SVP, Head of Fin, Admin | S - Sale | $45.12 | -2,752 | 111.3K | -2% | -$124.2K |
| MT | 2024-06-11 | 2024-06-10+ | DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | SVP, Head of Fin, Admin | S - Sale | $30.74 | -2,921 | 115.1K | -2% | -$89.8K |
| MT | 2024-05-17 | 2024-05-16 | DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | SVP, Head of Fin, Admin | S - Sale | $28.27 | -2,588 | 116.7K | -2% | -$73.2K |
| DMT | 2024-03-12 | 2024-03-08+ | DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | SVP, Head of Fin, Admin | S - Sale+OE | $26.19 | -88.9K | 119.3K | -43% | -$2.33M |
| DMT | 2024-03-12 | 2024-03-08 | DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | SVP, Head of Fin, Admin | M - OptEx | $5.54 | +86.3K | 190.9K | +82% | +$477.8K |
| T | 2024-03-11 | 2024-03-07 | DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | SVP, Head of Fin, Admin | S - Sale | $25.85 | -2,273 | 122.0K | -2% | -$58.8K |
| DMT | 2024-03-01 | 2024-02-29+ | DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | SVP, Head of Fin, Admin | M - OptEx | $1.03 | +12.7K | 133.5K | +11% | +$13.1K |
| DMT | 2024-03-01 | 2024-02-29+ | DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | SVP, Head of Fin, Admin | S - Sale+OE | $28.05 | -12.7K | 124.8K | -9% | -$357.3K |
| DT | 2024-01-26 | 2024-01-26 | DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | SVP, Head of Fin, Admin | S - Sale+OE | $24.34 | -13.0K | 124.2K | -9% | -$316.4K |
| DT | 2024-01-26 | 2024-01-26 | DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | SVP, Head of Fin, Admin | M - OptEx | $1.03 | +13.0K | 137.2K | +10% | +$13.4K |
| DT | 2024-01-04 | 2024-01-03 | DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | SVP, Head of Fin, Admin | M - OptEx | $1.03 | +13.0K | 137.2K | +10% | +$13.4K |
| DT | 2024-01-04 | 2024-01-03 | DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | SVP, Head of Fin, Admin | S - Sale+OE | $18.81 | -13.0K | 124.2K | -9% | -$244.5K |
| 2023-12-14 | 2023-12-14 | DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | See Remarks | S - Sale | $12.02 | -2,376 | 124.2K | -2% | -$28.6K | |
| 2023-12-12 | 2023-12-11 | DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | See Remarks | S - Sale | $10.72 | -1,380 | 126.6K | -1% | -$14.8K | |
| M | 2023-12-06 | 2023-12-04+ | DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | See Remarks | S - Sale | $12.01 | -2,553 | 128.0K | -2% | -$30.7K |
| D | 2023-11-16 | 2023-11-15 | DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | See Remarks | A - Grant | $0.00 | +89.7K | 130.5K | +220% | $0 |
| 2023-09-20 | 2023-09-18 | DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | See Remarks | S - Sale | $9.41 | -1,290 | 40.8K | -3% | -$12.1K | |
| 2023-09-13 | 2023-09-12 | DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | See Remarks | S - Sale | $10.41 | -1,397 | 42.1K | -3% | -$14.5K | |
| DM | 2023-06-15 | 2023-06-13+ | DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | See Remarks | S - Sale+OE | $12.71 | -51.4K | 43.5K | -54% | -$653.2K |
| D | 2023-06-15 | 2023-06-13 | DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | See Remarks | M - OptEx | $1.03 | +40.0K | 93.5K | +75% | +$41.2K |
| 2023-03-15 | 2023-03-14 | DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | See Remarks | S - Sale | $13.33 | -1,311 | 54.9K | -2% | -$17.5K | |
| D | 2022-12-13 | 2022-12-12 | DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | See Remarks | S - Sale | $10.87 | -312 | 56.2K | -0.6% | -$3,391 |
| D | 2022-12-13 | 2022-12-09 | DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | See Remarks | A - Grant | $0.00 | +31.0K | 56.5K | +122% | $0 |
| 2022-09-21 | 2022-09-20 | DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | See Remarks | D - Sale to Iss | $13.70 | -840 | 25.5K | -3% | -$11.5K | |
| 2022-09-15 | 2022-09-15 | DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | See Remarks | D - Sale to Iss | $14.05 | -326 | 26.3K | -1% | -$4,580 | |
| 2022-06-15 | 2022-06-14 | DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | See Remarks | D - Sale to Iss | $4.95 | -333 | 26.7K | -1% | -$1,648 | |
| 2022-03-14 | 2022-03-11 | DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | See Remarks | S - Sale | $8.73 | -308 | 27.0K | -1% | -$2,689 | |
| D | 2021-12-14 | 2021-12-10 | DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | See Remarks | A - Grant | $0.00 | +16.7K | 27.3K | +157% | $0 |
| M | 2021-09-22 | 2021-09-20+ | DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | See Remarks | S - Sale | $15.90 | -859 | 11.1K | -7% | -$13.7K |
Purchase Sale Sale after option exercise All abbreviations